Bifidobacterium breve is a naturally occurring beneficial bacterium found in the human gut, particularly abundant in breastfed infants, and is one of the more well-studied probiotic species. Research suggests it may play a supportive role in digestive health by helping maintain a balanced gut microbiome and strengthening intestinal barrier function. Studies indicate promising results in the area of eczema relief, especially in infants and young children, where supplementation has been associated with reduced skin inflammation and improved symptoms. Additionally, emerging research points to potential benefits for immune modulation, skin health more broadly, and even weight management, though findings in these areas are still evolving. Commonly available in probiotic capsules and specialized infant formulations, B. breve continues to attract scientific interest for its versatile and gentle profile.
Compare this supplementResearch suggests that Bifidobacterium breve may support gut health across multiple life stages and contexts, with st...
View studies →Research suggests that Bifidobacterium breve may play a meaningful role in modulating immune function, with studies p...
View studies →Research suggests that Bifidobacterium breve may support skin health primarily through its influence on the gut-skin ...
View studies →Research suggests that evidence directly linking Bifidobacterium breve to weight management in humans remains limited...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 99,999,999.99 CFU | Daily | Immune function support in adults | Common dose range in clinical trials assessing immune markers and infection prevention |
| Capsule | 99,999,999.99 CFU | Daily | Skin health and reduction of skin dryness or inflammation | Common in clinical trials studying probiotic effects on skin barrier function and hydration |
| Powder | 99,999,999.99 CFU | Daily | Eczema relief and atopic dermatitis in infants and children | Common in clinical trials using B. breve M-16V and similar strains for atopic eczema |
| Powder | 99,999,999.99 CFU | Daily | Gut health and gastrointestinal symptom relief | Based on RCTs examining intestinal microbiota modulation and bowel regularity |
| Powder | 99,999,999.99 CFU | Daily | Weight management and metabolic health | Based on RCTs including B. breve B-3 strain studies on body fat reduction |